COGNICURRENT

Anvisa has banned over 150 intimate gels and erotic extracts from being sold due to lack of proper registration and safety evaluations.

A groundbreaking Brazilian study on polylaminin shows promising results in restoring movement after severe injuries, with a pivotal clinical study approved by Anvisa set to begin next month.

The Brazilian health regulator Anvisa has ordered the recall and immediate suspension of the injectable antibiotic Kefadim due to a packaging error that led to the mislabeling of its contents.

The National Health Surveillance Agency (Anvisa) in Brazil has introduced new regulations to facilitate the cultivation of cannabis and improve research opportunities.

Anvisa has reported 65 notifications of suspected deaths related to the use of weight loss medications known as pens between December 1, 2018, and December 7, 2025.

Brazil's health regulatory agency Anvisa has seized counterfeit batches of several drugs including Mounjaro and prohibited the compounding of hormonal implants.

The Brazilian health agency's recent measures to regulate the use and cultivation of medicinal cannabis are criticized for lacking robust scientific evidence and potentially leading to increased drug dependence and crime.

Brazil's health regulatory agency, Anvisa, reports 65 suspected deaths linked to the use of weight loss pens from December 2018 to December 2025, with a significant increase in reported adverse events.

Compounding pharmacies in Brazil are reportedly offering illegal weight loss injection sales to doctors, along with profit-sharing proposals.

Brazil's National Health Surveillance Agency (Anvisa) is expected to announce its decision regarding the registration of national versions of semaglutide-based pens, essential for diabetes treatment, next week.

Anvisa, Brazil's health regulatory agency, is expected to make a decision in the coming weeks regarding the approval of two competitors to Ozempic and Wegovy, as the substance semaglutide loses its patent.

Brazil's health agency warns about the risks of using weight loss pens without medical supervision, highlighting potential severe side effects.

Anvisa has approved guidelines to allow electronic issuance of controlled prescriptions in Brazil, set to be implemented on June 1.

The Brazilian National Health Surveillance Agency (Anvisa) has issued a warning regarding the use of hair pomades during Carnival, highlighting potential risks associated with unapproved products.

Three patients who received polylaminin as part of a court order have died in Brazil, with deaths attributed to pre-existing medical issues, according to the producing laboratory.

Anvisa suspends several batches of Nestlé's Alfamino infant formula due to excess levels of selenium and iodine, which the company attributes to a technical error in reporting.

Anvisa has suspended the sale of Nestlé’s Alfamino infant formula after detecting excessive levels of selenium and iodine exceeding health regulations.

Brazil's health regulatory agency Anvisa has issued a warning about the risks associated with improperly using weight loss pens, including acute pancreatitis, which can be fatal.

Brazil's health regulatory agency Anvisa has approved a new indication for the HPV vaccine Gardasil 9 to prevent oropharyngeal, head, and neck cancers in individuals aged 9 to 45.

Brazil's health agency Anvisa has issued a warning regarding the misuse of weight loss pens, highlighting a link to acute pancreatitis.

The director of Brazil's Anvisa agency stated that newly established limits for cannabis cultivation will not hinder the production of cannabis-based medicines.

Anvisa has issued a warning about the risks associated with the use of weight-loss pens after an investigation into pancreatitis cases linked to their usage found suspicious fatalities in Brazil.

The article discusses various significant news items, including a warning from Anvisa regarding slimming pens, China's reduction of investment in the US leading to a lower dollar, and other local incidents in Brazil.

Brazil's Anvisa has published regulations for the cultivation and research of medicinal cannabis, effective from August 4th.

The news report covers multiple stories including the Brazilian dollar's decline, health and safety alerts from Anvisa, a proposal on work schedules, legal issues involving a pilot and children, cannabis cultivation regulations, and a serious health incident during a swimming class.

Brazil's health regulatory agency, Anvisa, has issued a warning regarding the dangerous use of weight-loss pens, citing potential health risks including severe pancreatitis and death.

ANVISA issues a warning after a rise in pancreatitis notifications related to weight loss pens.

The video report discusses the Brazilian economy with the dollar dropping to a low of R$ 5.18, various health alerts, and significant incidents involving individuals and institutions.

Anvisa has issued a warning following a spike in pancreatitis notifications related to weight loss pens.

ANVISA has issued a warning following an increase in pancreatitis notifications linked to weight loss pens, while Brazil is investigating six deaths associated with the medication.

Anvisa has issued an alert about the risk of pancreatitis linked to the use of weight loss pens, following reports of six deaths associated with GLP-1 receptor antagonists.

Brazil's health agency Anvisa warns against the use of weight loss pens for obesity and diabetes treatment without medical oversight due to rising cases of pancreatitis.

Brazil is investigating six deaths due to pancreatitis linked to the use of weight-loss pens, with major brands involved and concerns over counterfeit products.

Brazil's health regulatory agency Anvisa has reported six suspected deaths related to pancreatitis connected to weight loss pens used from 2020 to 2025.

The Brazilian health authority, Anvisa, has reported six suspected deaths and 225 cases of pancreatitis linked to weight loss pens since 2018, prompting discussions about their safety.

The Brazilian National Health Surveillance Agency (Anvisa) has suspended and prohibited several food products deemed irregular, including açaí coffee marketed as a disease treatment, plastic glitters used in baking, and a batch of olive oil.

A 38-year-old woman was arrested in Mato Grosso for allegedly purchasing a weight-loss drug prohibited in Brazil, admitting awareness of its illegal status.

Over 90,000 doses of the flu vaccine in São Paulo's health posts are being discarded despite still being valid due to regulations from the National Health Surveillance Agency (Anvisa).

Novo Nordisk has requested authorization from Anvisa to sell Wegovy in pill form in Brazil, with the request submitted on January 30, but the Brazilian regulatory agency has not yet responded.

The Brazilian Health Regulatory Agency Anvisa has temporarily banned a batch of semisweet condensed milk from the brand La Vaquita after finding unacceptable levels of Staphylococcus aureus bacteria in microbiological tests.

Anvisa has released regulations allowing the cultivation of medicinal Cannabis in Brazil, effective August 4, 2023, with specific rules for small associations and communities.

Novo Nordisk has requested authorization from Anvisa to sell Wegovy in tablet form in Brazil, following its launch in the U.S.

The National Health Surveillance Agency in Brazil has published resolutions detailing the regulations for cannabis cultivation, including an experimental regulatory environment for non-industrial supply models.

Anvisa has approved the use of semaglutide for adults with established cardiovascular disease or obesity to reduce the risk of heart attack and stroke.

Brazil's National Health Surveillance Agency (Anvisa) has approved semaglutide for reducing the risk of cardiovascular events, a drug popularized for weight loss efficacy.